* Look out below — investors are meaningfully underpricing risk. * "Slugflation" remains our base case — accompanied by a revaluation (lower) in price earnings multiples. * The Fed may be between a rock and a hard place.…
Read in context ›Bristol-Myers Squibb Stock (BMY)
Track Bristol-Myers Squibb stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
BMY
Bristol-Myers Squibb
healthcare
At close
$63.43
▲ +1.11 (+1.78%)
Nov 13, 4:00 PM ET
After-hours
$63.61
▲ +0.18 (+0.28%)
Nov 13, 7:56 PM ET
Market Cap
$129.66B
P/E Ratio
14.0x
1Y Return
+36.23%
EPS (TTM)
$4.51
Read the latest TheStreet Pro articles mentioning Bristol-Myers Squibb, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
63 articlesDaily Diary Mentions
1 mentionTrain Hundred and Two Is on the Wrong Track and Headed for You